Nasopharyngeal Carcinoma Profile in dr. Cipto Mangunkusumo Hospital Year 2013

Soehartati Argadikoesoema Gondhowiardjo; Lidya Meidania; Fajar Senoaji; Sri Mutya Sekarutami

doi:10.32532/jori.v10i1.98

Nasopharyngeal Carcinoma Profile in dr. Cipto Mangunkusumo Hospital Year 2013

Soehartati Argadikoesoema Gondhowiardjo, Lidya Meidania, Fajar Senoaji, Sri Mutya Sekarutami

Sari

Background: Nasopharyngeal carcinoma (NPC) remains as a health burden in Indonesia. It is one of most common cancers in Indonesia, with an overall incidence estimated at 6.2/100,000 or 12,000 new cases per year. Unfortunately, many of these cases are unregistered due to several factors, such as lack of national cancer registry. In most developing countries, cancer registration often begins in hospitals. Hospital-Based Cancer Registry (HBCR) provides the initial and major source of information on patients that leads to the set-up of a population-based registry.

Materials and Methods: This was a descriptive retrospective study of all registered NPC patient in HBCR, from January-December 2013. All registered NPC patients in HBCR in the year 2013 is included.

Results: There were 299 NPC patients, with a male-to-female ratio of 2.4:1. Median age was 47 years old, with majority of age between 40-49 years old (27.4%). Most common type of histology was undifferentiated NPC (85%). Most patients presented with locally advanced disease, with majority of stage IVA (33.9%). Chemoradiation remained as standard treatment for locally advanced NPC (84.1%).

Conclusion: Demographic data of patients, such as age and sex, are consistent with previous studies. Whereas racial distribution was not parallel with previous studies, maybe due to its lack of available data. Moreover, most common histopathology type and presentation was undifferentiated NPC and patients with Stage III to IV cancer.

Kata Kunci

Nasopharyngeal Carcinoma, NPC, Profile, Hospital-Based Cancer Registry, HBCR

Teks Lengkap:

PDF (English)

Referensi

Torre LA, Bray F, Siegel RL, Ferlay J. Global Cancer Statistics , 2012. 2015;65(2):87–108.

Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index ( 2008 – 2030 ): a population- based study. Lancet Oncol 2016;13(8):790–801.

Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar 2013. Jakarta: 2013.

Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 2012;31(4):185–96.

Valsecchi M, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity. Lancet Oncol 2008;9:159–67.

Tang L-L, Chen W-Q, Xue W-Q, He Y-Q, Zheng R-S, Zeng Y-X, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 2016;374(1):22–30.

Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011;30(2):114–9.

Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15(10):1765–77.

Wei K-R, Yu Y-L, Yang Y-Y, Ji M-F, Yu B-H, Liang Z-H, et al. Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pacific J Cancer Prev 2010;11(1):29–32.

Xie S, Yu IT, Tse L, Mang OW, Yue L. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983 – 2008 : Suggestion of apotential protective role of oestrogen. Eur J Cancer 2013;49(1):150–5.

Xiao G, Cao Y, Qiu X, Wang W, Wang Y. Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. BMC Cancer 2013;13(1):226.

Wang Y, Zhang Y, Ma S. Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol 2013;37(6):793–802.

Tan L, Loh T. Benign and malignant tumors in nasopharynx. In: Flint P, Haughey BH, Lund V, et al, editors. Cummings Otolaryngology. 6th ed. Philadelpia:Saunder, 2015. p. 1420-31

Wildeman MA, Fles R, Herdini C, Indrasari RS, Vincent AD, Tjokronagoro M, et al. Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia. PLoS One 2013;8(5):1–6.

Riri Y, Gondhowiardjo S. Profil kanker nasofaring yang mendapat terapi radiasi dan atau kombinasi di departemen radioterapi RSCM dengan tinjauan pada kesintasan [Tesis]. Jakarta: Universitas Indonesia; 2013.

Lok B, Setton J, Ho F, Riaz N, Rao S, Lee N. Nasopharynx. In: Halperin E, Wazer D, Perez C, Brady L, editors. Perez and Brady’s Principles and Practice of Radiation Oncology. Philadelpia: Lippincot Williams & Wilkins; 2013. p. 730–60.

Chan ATC, Grégoire V, Lefebvre J-L, Licitra L, Hui EP, Leung SF, et al. Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:2010–2.

1NCCN. NCCN Guidelines: Head and Neck Cancers version1.2015. NCCN; 2015.

Chen Y, Guo R, Liu NA, Liu X, Mao Y-P, Tang L-L, et al. Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma : a Bayesian network meta-analysis of randomized controlled trials. J Cancer 2015;6(9):883-92.

DOI: https://doi.org/10.32532/jori.v10i1.98 <